Results 11 to 20 of about 55,991 (251)
Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2022 Hypertrophic cardiomyopathy (HCM) is a primary disease affecting the cardiac muscle and is characterized by heterogeneous genetic, morphological, functional and clinical features. The clinical presentation of HCM varies widely. Patients may be completely asymptomatic and identified incidentally.
Sarita Gore, Sunil Yogiraj Swami
openaire +2 more sources
Journal of Cardiovascular Development and Disease, 2023 Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy resulting from a mutation in one of several cardiac sarcomeric proteins [...]
Asra K. Butt +7 more
openaire +3 more sources
Hypertrophic Cardiomyopathy [PDF]
Heart Failure Clinics, 2010 Important insights into the molecular basis of hypertrophic cardiomyopathy and related diseases have been gained by studying families with inherited cardiac hypertrophy. Integrated clinical and genetic investigations have demonstrated that different genetic defects can give rise to the common phenotype of cardiac hypertrophy. Diverse pathways have been
Christopher, Critoph, Perry, Elliott
openaire +4 more sources
Availability and Utilization of Automated External Defibrillators in New York State Schools
Frontiers in Pediatrics, 2021 Background: Use of automated external defibrillators (AEDs) in out-of-hospital cardiac arrests (OHCAs) improve survival. Professional health organizations recommend that AEDs be available in crowded places, including schools but currently only 18 US ...
Milla Arabadjian +3 more
doaj +1 more source
Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy
Scientific Reports, 2021 Hypertrophic cardiomyopathy (HCM) is characterized by phenotypic heterogeneity. We investigated the molecular basis of the cardiac phenotype in two mouse models at established disease stage (mouse-HCM), and human myectomy tissue (human-HCM).
Styliani Vakrou +11 more
doaj +1 more source
IJC Heart & Vasculature, 2020 Hypertrophic cardiomyopathy (HCM) is the most common monogenic heart disease affecting at least 1 in 500 people worldwide. The hallmark of the disease is left ventricular hypertrophy in the absence of cardiac or systemic disease that may cause hypertrophy. The disease can present at any age and is highly variable.
Christiaans, Imke +2 more
openaire +5 more sources
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016 BackgroundThe subcutaneous implantable cardioverter defibrillator (S‐ICD) has been developed to avert risks associated with transvenous defibrillator leads. The technology is attractive for younger patients, such as those with hypertrophic cardiomyopathy
Jonathan Weinstock +4 more
doaj +1 more source
COVID-19 in Adults With Hypertrophic Cardiomyopathy
Frontiers in Cardiovascular Medicine, 2021 Background: Individuals with cardiovascular disease are considered high risk for severe COVID-19. However, the clinical impact of COVID-19 in patients with hypertrophic cardiomyopathy (HCM) is unknown.
Milla E. Arabadjian +4 more
doaj +1 more source
Weight loss in hypertrophic cardiomyopathy: A clinical case series
International Journal of Cardiology. Cardiovascular Risk and Prevention, 2023 Background: Obesity is prevalent among patients with hypertrophic cardiomyopathy (HCM). Obese HCM patients have greater wall thickness, LV mass, worse hemodynamic function and NYHA class. Weight loss may favorably influence the HCM phenotype.
Maria C. Reuter +6 more
doaj +1 more source
AIP Advances, 2021 Quickly and accurately segmenting the left ventricular (LV) myocardium from ultrasound images and measuring the thickness of the interventricular septum and LV wall play an important role in hypertrophic cardiomyopathy.
Shenghan Ren +5 more
doaj +1 more source